Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emblem Corp EMMBF

Healthcare Biotechnology Cannabis
"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."


OTCPK:EMMBF - Post by User

Emblem Corp > Sell this company
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Dmcflaxon Oct 20, 2018 12:45am
146 Views
Post# 28839832

RE:RE:RE:RE:RE:RE:Sell this company

RE:RE:RE:RE:RE:RE:Sell this companyBought into this 18 months ago on my measly tfsa account because of the name John Stewart. Am so flipping tired of waiting for something to bring me back up high enough to sell, I’m selling, disappointed. Oh well. Move on. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities